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Injury to peripheral nerves results in the infiltration of immune
cells, which remove axonal- and myelin-derived material.
Schwann cells could play a key role in this process by regulating
macrophage infiltration. We show here that medium conditioned
by primary denervated Schwann cells or the Schwannoma cell line
RN22 produces chemotactic activity for macrophages. The pres-
ence of blocking antibodies to macrophage chemoattractant pro-
tein-1 (MCP-1) or leukemia inhibitory factor (LIF) reduced this
activity to 35 and 65% of control levels, respectively, and only
15% remained in the presence of both antibodies. The presence
of chemotactic LIF in Schwann cell-conditioned medium was
confirmed by using cells from lif/ mice. Although interleukin-6
(IL-6) is not itself a chemotactic factor, we found that medium from
il-6/ nerves showed only 40% of the activity secreted by
wild-type nerves. Furthermore, IL-6 rapidly induced LIF mRNA in
primary Schwann cells, and LIF rapidly induced MCP-1 mRNA
expression. Treatment of RN22 Schwannoma cells with IL-6 or LIF
enhanced the secretion of the chemotactic activity of these cells.
These observations show that Schwann cells attract macro-
phages by secreting MCP-1 and LIF. They also provide evi-
dence for an autocrine-signaling cascade involving IL-6, LIF,
and MCP-1, which amplifies the Schwann cell-derived chemo-
tactic signals gradually, in agreement with the delayed entry of
macrophages to injured nerves.
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Injury to peripheral nerve initiates a complex cascade of signals
involving neurons, glia, and cells of the immune system that leads
to Wallerian degeneration (for review, see Scherer and Salzer,
2001). An important component of this process is the invasion of
macrophages. For many years, there have been uncertainties
regarding the role of Schwann cells in regulating this macrophage
recruitment (Beuche and Friede, 1984; Scheidt and Friede, 1987;
Stoll et al., 1989). Two features of the myelomonocytic response
in damaged peripheral nerves distinguish it from that seen in
non-neuronal tissues (Perry and Brown, 1992): (1) after cut or
crush injury, only small numbers of neutrophils are found in the
distal segment, and (2) there is a delay of 2 or 3 d before a major
influx of macrophages (Ramon y Cajal, 1928; Beuche and Friede,
1984; Crang and Blakemore, 1986; Perry et al., 1987; Stoll et al.,
1989). This delay is consistent with the idea that the signals that
most effectively attract macrophages are generated by a relatively
slow-moving signaling cascade. This cascade is probably triggered
by factors arising in proliferating dedifferentiating Schwann cells,
as highlighted by observations on C57BL/Ola mice. Nerve injury
in these mice does not induce acute Schwann cell dedifferentia-
tion and myelin breakdown, and macrophage invasion is sparse
and slow (Lunn et al., 1989; Perry et al., 1990; Glass et al., 1993;
Mack et al., 2001). This is attributable to protection offered by a
chimeric gene containing an N-terminal fragment of ubiquitina-
tion factor E4B fused to nicotinamide mononucleotide adenyl-
transferase (Mack et al., 2001).
Cytokines induced in Schwann cells after peripheral nerve
injury could play a key role in the interactions between Schwann
cells and macrophages. The neuropoietic cytokines leukemia
inhibitory factor (LIF) and interleukin-6 (IL-6) are both involved
in the neuronal and immune responses to injury (Patterson, 1994;
Gadient and Patterson, 1999). Schwann cells in transected nerves
upregulate expression of LIF and IL-6 (Banner and Patterson,
1994; Curtis et al., 1994; Bolin et al., 1995; Bourde et al., 1996;
Kurek et al., 1996). Moreover, LIF (but not IL-6) induces che-
motaxis of peritoneal macrophages, and macrophage infiltration
into injured sciatic nerve is delayed in LIF knock-out mice
(Sugiura et al., 2000). Another potential Schwann cell-derived
macrophage attractant, monocyte chemoattractant protein-1
(MCP-1), attracts macrophages in other systems and is induced in
Schwann cells by nerve transection with a time course that lags
behind that of LIF and IL-6 (Murphy, 1994; Baggiolini, 1998;
Toews et al., 1998; Siebert et al., 2000). Schwann cells also
produce a number of other cytokines, including IL-1, tumor
necrosis factor- (TNF-), and IL-8 (Bergsteinsdottir et al.,
1991; Wagner and Myers, 1996; Rutkowski et al., 1999).
Thus, although Schwann cells deprived of axonal contact in
transected nerves express several signals that might act on mac-
rophages, it has not been shown directly that these Schwann cells
produce macrophage chemotactic activity. Moreover, although
there are many studies on cytokine induction after peripheral
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nerve injury, little is known about the mechanisms that regulate
their expression. A recent paper pinpoints TNF- as an inducer
of MCP-1 in Schwann cells after nerve injury, particularly at the
relatively late time of 4 d (Subang and Richardson, 2001). Here,
we have examined signals that might contribute to Schwann
cell-derived chemotactic activity at earlier time points and stud-
ied how their expression is regulated. We have directly measured
macrophage chemotactic activity generated by normal Schwann
cells, RN22 Schwannoma cells, and cut nerves taken from LIF
and IL-6 knock-out animals. We find that LIF and MCP-1 are
important components of the secreted signals that attract macro-
phages. We also provide evidence for an autocrine-signaling
cascade involving IL-6, LIF, and MCP-1 in Schwann cells that
could result in a gradual amplification of the macrophage attract-
ing activity secreted by these cells.
MATERIALS AND METHODS
Defined medium. For all conditioned media, we used a supplemented
defined medium identical to that used in previous studies (Jessen et al.,
1994). It consists of a 1:1 mixture of DMEM and Ham’s F-12 supple-
mented with insulin (5 g/ml), transferrin (100 g/ml), glutamine (1
mM), progesterone (60 ng/ml), putrescine (16 g/ml), selenium (160
ng/ml), T4 (400 ng/ml), T3 (10.1 ng/ml), bovine serum albumin (BSA)
(0.035%), penicillin (100 IU/ml), and streptomycin (100 IU/ml). For all
conditioned media, 20 M leupeptin was added to the defined medium to
prevent proteolysis. Sources of the reagents used have been detailed in
previous papers (Jessen et al., 1994; Meier et al., 1999).
Schwann cell cultures and conditioned medium preparation. Sciatic
nerves from 4-d-old rats were dissociated, and Schwann cells were puri-
fied by immunopanning to remove contaminating cells, essentially as
described previously (Jessen et al., 1990, 1994; Lee et al., 1997). Schwann
cells were resuspended in defined medium, counted, and plated onto
laminin-coated coverslips for immunostaining with anti-S100 antibodies as
described previously (Meier et al., 1999). This confirmed that Schwann cells
are 99.5  0.5% pure after immunopanning. For conditioned medium
preparation, Schwann cells were plated onto 35-mm-diameter poly-L-lysine
and laminin-coated tissue culture plastic dishes (4.5–7  10 5 cells total).
After 24 hr of incubation, the conditioned medium was collected, centri-
fuged for 10 min at 1000 rpm, and stored in BSA (3 mg/ml)-coated
cryotubes at 80°C until further use. For LIF- or IL-6-treated primary
Schwann cells, recombinant mouse LIF or recombinant rat IL-6 (R & D
Systems, Oxon, UK) was added to the cultures at two different concentra-
tions, 2 and 20 ng/ml, always accompanied by a control with no treatment.
Cells were incubated under standard conditions (37°C, 5% CO2) for 1 and
3 hr (LIF) and for 1, 3, 6, 10.5, and 24 hr (IL-6).
RN22 Schwannoma cell-conditioned medium. Cells were grown in
Roswell Park Memorial Institute (RPMI)-1640 (Sigma-Aldrich, Poole,
UK) containing 10% fetal calf serum (Sigma-Aldrich) until they reached
70% confluence. Subsequently, they were changed to defined medium
and left for 24 hr to adapt to the new conditions. Fresh medium was then
added, and the cell line was treated with 20 ng/ml LIF or IL-6. After a
3 hr incubation in 37°C/5% CO2, the cells were washed three times, and
fresh defined medium was added. After an additional 24 hr incubation,
the conditioned medium was removed, centrifuged for 10 min at 1000
rpm, and stored at 80°C until further use.
Mouse sciatic nerve conditioned medium. The strain of LIF knock-out
(lif/) mice used in this work was that of Stewart et al. (1992), which
has been intermittently back-crossed with C57BL/6 to maintain fertility
and viability. The IL-6 knock-out strain (il-6/) was produced by Kopf
et al. (1994) and was purchased from The Jackson Laboratory (Bar
Harbor, MA.) Sciatic nerves were excised from wild-type, lif/, il-
6/, as well as LIF/IL-6 double knock-out (lif/il-6/) mice. The
nerves were cleaned of debris, cut in 2 mm pieces, and cultured in 24 well
plates for 24 and 48 hr. The supernatant was aliquoted for storage as
described above.
Peritoneal macrophages and chemotaxis assay. BALB/c mice between 8
and 10 weeks of age were injected intraperitoneally with 2 ml of 10%
protease peptone (Difco, Detroit, MI). Four days later, peritoneal exu-
date cells were collected by lavage of the peritoneal cavity with 5 ml of
ice-cold PBS. After washing with PBS, the peritoneal cells were resus-
pended at a concentration of 10 6/ml in RPMI-1640 containing 0.1%
BSA. Chemotactic activity was assayed in a multiwell microchamber
AP48 (Neuroprobe, Gaithersburg, MD) (Falk et al., 1980) after optimal
chemotaxis conditions were established (Sugiura et al., 2000). This
method of measuring chemotaxis is now widely used and is thought to
minimize complications associated with earlier assays (Wilkinson, 1982;
Bignold, 1988). Briefly, 25 l of chemoattractant was added to the bottom
wells. A polycarbonate filter sheet (25  80 mm, 8 m pores; Nucleopore
Corp., Pleasanton, CA), without polyvinylpyrrolidone coating to prevent
migrated cells from falling off (Harvath et al., 1980), was placed on top
of the wells in the bottom plate. The gasket and top plate were fixed in
place, and the upper wells were carefully loaded with 50 l of cell
suspension (5  10 4 cells). The assembly was incubated for 100 min at
37°C with 5% CO2 in humidified air. After incubation, the top plate,
gasket, and filter were removed; cells on the top of the filter that had not
migrated through were wiped off; and the filter was fixed and stained with
Hema color (Harleco, Gibbstown, NJ). All cells that had migrated were
counted under light microscopy at 400 magnification. Data are pre-
sented as the chemotactic index, which is defined as the number of cells
that migrated in the presence of a test protein or conditioned medium
divided by the number of cells that migrated in the presence of medium
alone (Sugiura et al., 2000). In each experiment, the efficiency of migra-
tion was monitored using recombinant MCP-1 as a positive control.
Experiments in which the chemotactic index obtained with MCP-1 at 10
ng/ml was 3 were discarded.
Antibody blocking. Anti-LIF and anti-MCP-1 antibodies (R & D
Systems) were used at a concentration of 50 g/ml. In control experi-
ments, we confirmed that antibodies to MCP-1 block the activity of
murine MCP-1. We also confirmed the specificity of the blocking exper-
iments by showing that blocking antibodies for neurotrophin-3 (NT-3)
(2.5 g/ml), a factor that is secreted into Schwann cell-conditioned
medium (Meier et al., 1999), or hepatocyte growth factor (5 g/ml), a
known chemoattractant (Galimi et al., 2001), do not inhibit the chemo-
tactic activity.
Isolation of RNA and first-strand cDNA synthesis. Total RNA was
prepared using Ultraspec reagent (Biotecx, Houston, TX) or TRIzol
reagent (Invitrogen, Carlsbad, CA), according to the manufacturers’
instructions. Total RNA from immunopanned Schwann cells and from
intact nerves was quantified by measuring the optical density at 260 and
280 nm and analyzed for integrity by agarose gel electrophoresis under
denaturing conditions.
Semiquantitative reverse transcriptase-PCR. One microgram (LIF-
treated Schwann cell cultures), 2 g (intact nerve, Schwann cell cultures,
and IL-6-treated Schwann cell cultures) total RNA was reverse-
transcribed into cDNA in a 50 l reaction containing 50 mM Tris-HCl,
pH 8.3, 75 mM MgCl2, 10 mM DTT, 0.5–1.5 mM deoxyNTPs (dNTPs),
and either 100–300 ng of random hexamers or 500 ng of oligo-dT17–18 as
primer and 200–300 U of Superscript II reverse transcriptase (RT) (In-
vitrogen). The reaction was incubated for 90 min at 42°C, followed by 10
min at 70°C. The remaining RNA was denatured by adding 1 l of RNase
A (10 mg/ml; Boehringer Mannheim, East Sussex, UK) and incubating for
30 min at 37°C. The relative amount of cDNA synthesized from each
sample was determined by PCR amplification using specific primers for 18S
or glyceraldehyde-3-phosphate dehydrogenase (GAPDH). The primer
pairs were designed as follows (product size in parentheses): MCP-1
forward primer, 5-ctgggcctgttgttcacagttgc-3; MCP-1 reverse primer, 5-
gttggtggagttcgtgaagacatc-3 (380 bp) (Sun et al., 1997); macrophage inhib-
itory protein-1 (MIP-1) forward primer, 5-gaaggtctccaccactgcccttgc-3;
MIP-1 reverse primer, 5-gactcgaccttgacttacggact-3 (350 bp) (Sun et al.,
1997); LIF forward primer, 5-ccgtgtcacggcaacctcatgaaccagatc-3; LIF re-
verse primer, 5-ggggacacagggcacatccacatggcccac-3 (395 bp) (Patterson
and Fann, 1992); inducible nitric oxide synthase (iNOS) forward primer,
5-tgatgtgctgcctctggtct-3; iNOS reverse primer, 5-acttcctccaggatgttgta-3
(350 bp) (Bonmann et al., 1997); 18S forward primer, 5-cctcgaaagagtcct-
gta-3; 18S reverse primer, 5-gggaacgcgtgcatttat-3 (350 bp) (Blanchard et
al., 1996); GAPDH forward primer, 5-ttccagtatgactctaccc-3; and GAPDH
reverse primer, 5-atggactgtggtcatgagccc-3 (398 bp) (Brown et al., 1997).
One microliter of cDNA from each sample was amplified in a 50 l PCR,
containing 1 reaction buffer (10 mM Tris-HCl, pH 9.0, 50 mM KCl, and
0.1% Triton X-100); 1–2 mM MgCl2, 0.2 mM dATP, dGTP, dTTP, and
dCTP; a 0.5 mM concentration of each primer listed above; and 1.5 U of
Taq DNA polymerase (Invitrogen). The cDNA was amplified after deter-
mining the optimal number of cycles and annealing temperature for each
primer: 18S, 21 cycles; MCP-1, 25 cycles when oligo-dT17–18 primers were
used or 35 cycles when random hexamers were used for reverse transcrip-
tion; MIP-1 and iNOS, 35 cycles; and LIF, 35 cycles. For MCP-1 and
MIP-1, PCRs were performed under a hot start program (94°C for 4.5
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min). Cycling conditions were as follows: the mixture was initially incu-
bated once for 3 or 5 min at 94°C; denatured at 94°C for 30 sec or 1 min;
and annealed at 50°C (MCP-1), 55°C (18S), 57°C (LIF and GAPDH), or
60°C (iNOS and MIP-1) for 1 min, followed by 72°C for 30 sec or 1 min
with an extension of 5 min. The number of cycles used for semiquantitative
PCR was in the linear part of the amplification profile.
Relative quantification of RT-PCR products. The intensity of the PCR
products was measured using densitometry (Scion Image 1.62c software;
Scion Corp., Frederick, MD), and the ratio of the intensity of MCP-1 and
LIF signal to 18S and/or GAPDH was calculated for each sample. These
ratios were compared at the indicated time points to obtain a numerical
estimate of the changes in the cDNA of interest after treatment with
either IL-6 or LIF.
Statistical analysis. All results are presented as mean  SEM. The
statistical significance of differences in macrophage migration toward
putative stimuli versus medium controls was analyzed by Student’s t test.
All experiments were performed three times, four replicates each, unless
otherwise stated.
RESULTS
Primary Schwann cells secrete chemotactic activity
Although in situ hybridization and other studies of transected
nerves show that injury induces cytokine and chemokine mRNAs
in Schwann cells (see the introductory remarks), it has not been
shown directly that Schwann cells secrete macrophage chemotac-
tic activity. To test this, we used cultures of primary Schwann cells
as a model of denervated Schwann cells in the distal stump of cut
nerves. This is because there is little evidence for a major qual-
itative difference in molecular expression between Schwann cells
in distal nerve stumps and Schwann cells cultured in vitro in the
absence of neurons, with the possible exception of nerve growth
factor (Mirsky and Jessen, 1990). For comparison, we also used
segments cut from mouse sciatic nerves placed in culture without
dissociation and the Schwannoma cell line RN22. If Schwann cells
secrete chemotactic signals, medium conditioned by these tissues
should induce macrophage chemotaxis. We tested this using the
AP48 microchamber assay. We found that defined medium con-
ditioned for 24 hr by dense cultures of immunopanned Schwann
cells from nerves of 4-d-old rats, nerve segments, or the RN22 cell
line all contained significant chemotactic activity (Fig. 1A). The
chemotactic index for all three media was similar when compared
with the migration stimulated by the well established macrophage
attractant MCP-1 (10 ng/ml) in parallel experiments on sister
cultures. The Schwann cell-conditioned medium was shown to act
in a dose-dependent manner (Fig. 1B).
MCP-1 and LIF are components of the Schwann cell-
derived chemotactic activity
Concerning the identity of the Schwann cell-derived chemotactic
signals, we initially considered MCP-1, in view of its potent
chemotactic and activating properties in macrophage migration
assays and in view of other evidence that MCP-1 is a component
of the regulatory cascades that attract macrophages into cut
nerves in vivo (Toews et al., 1998; Siebert et al., 2000; Subang and
Richardson, 2001). First, we tested whether MCP-1 is upregu-
lated when Schwann cells are removed from axonal contact and
cultured under conditions used to generate the conditioned me-
dium. RT-PCR was used to compare mRNA from freshly isolated
intact nerves representing Schwann cells in normal contact with
axons both with mRNA from immunopurified Schwann cells after
a 24 hr period in vitro and with mRNA from unpurified cultures
of dissociated nerve containing both Schwann cells and fibroblasts
isolated after a 24 hr period in vitro. In addition to MCP-1
mRNA, we also examined mRNA for the related -chemokine
MIP-1 and for iNOS, an enzyme upregulated in Schwann cells
in response to treatment with the inflammatory cytokines
interferon- or TNF- (Gold et al., 1996). This comparison
showed that whereas intact nerves expressed undetectable levels
of these molecules, purified primary Schwann cells selectively
upregulated MCP-1. In contrast, mixed cultures containing both
Schwann cells and fibroblasts expressed all signals tested (i.e.,
MCP-1, MIP-1, and iNOS) (Fig. 2).
Therefore, we tested whether the chemotactic activity present
in medium conditioned by purified Schwann cells could be inhib-
ited by antibodies that selectively neutralize MCP-1. We ex-
tended these experiments to include antibodies that neutralize
LIF, because this cytokine is induced in Schwann cells by sciatic
nerve injury in vivo and also has macrophage chemotactic activity
in vitro (Banner and Patterson, 1994; Sugiura et al., 2000). We
found that neutralizing antibodies against either MCP-1 or LIF
could inhibit the chemotactic activity in the conditioned medium
(Fig. 3A). The MCP-1 antibody blocked 60–70% of the activity
( p  0.0001), whereas the anti-LIF antibody blocked 30–40% of
the activity ( p  0.006). When the conditioned medium was
incubated with both antibodies, only 15% of the chemotactic
activity remained ( p  0.0001). We have shown previously that
the RN22 Schwann cell line, like Schwann cells, secreted a mac-
rophage chemoattractant (Fig. 1A). Supporting a major role for
Figure 1. Schwann cells secrete macrophage chemoattractant activity. A,
Immunopurified cells (SCH ), a Schwann cell line (RN22), and nerve
segments (NERVE) secrete macrophage chemoattractant activity. All
media were conditioned for 24 hr and used undiluted (see Materials and
Methods). For each of these three determinations, MCP-1 (10 ng/ml)
served as a positive control in a parallel assay as shown. Defined medium
served as negative control. In this and all subsequent illustrations of
migration assays, the results are expressed as chemotactic index (see
Materials and Methods). B, The Schwann cell-derived macrophage che-
motactic activity acts in a dose-dependent manner. Conditioned medium
(CM ) from immunopurified Schwann cells was used undiluted and at the
dilutions indicated.
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MCP-1 as a glial cell-derived chemotactic signal, we found that
neutralizing MCP-1 antibodies also blocked 60% of the RN22-
derived activity (Fig. 3B).
If LIF acts as a Schwann cell-derived chemoattractant, condi-
tioned medium from nerves of mice in which LIF has been
genetically inactivated should be relatively ineffective in attract-
ing macrophages. We tested this by comparing macrophage che-
motactic activity in media conditioned by nerve segments from
wild-type or lif/ mice (Fig. 4A). We found that medium from
lif/ nerves contained only 40% of the activity found in media
from wild-type nerves ( p  0.013), in agreement with the exper-
iments above using blocking antibodies.
Together, these experiments strongly indicate that MCP-1 and
LIF are the principal factors for macrophage chemotactic activity
directly secreted by Schwann cells.
Autocrine circuits involving IL-6 and LIF regulate the
secretion of chemotactic activity from Schwann cells
We then considered how the secretion of chemotactic agents such
as MCP-1 and LIF might be regulated. After axotomy in vivo,
LIF mRNA levels peak at 24 hr, whereas mRNA for the major
macrophage attractant MCP-1 does not reach peak levels until 48
hr after cutting (Banner and Patterson, 1994; Carroll and
Frohnert, 1998; Toews et al., 1998; Subang and Richardson,
2001). The relatively slow time course of MCP-1 induction sug-
gests the existence of earlier regulatory cascades triggered by
nerve transection. A number of factors point to IL-6 as a favor-
able candidate for such a role: (1) IL-6 mRNA is rapidly induced
by axotomy, reaching a peak at 12 hr (Bolin et al., 1995; Bourde
et al., 1996; Kurek et al., 1996), (2) IL-6 has been implicated
previously in neuronal and immune responses to injury (Gadient
and Patterson, 1999), and (3) although IL-6 does not itself attract
macrophages (Sugiura et al., 2000), cut nerves in il-6/ mice
show reduced macrophage recruitment (Klein et al., 1997), sug-
gesting that IL-6 attracts macrophages to nerves through an
indirect mechanism.
To test the involvement of IL-6, we compared the chemotactic
activity of medium conditioned by nerves from il-6/ mice with
conditioned medium from segments of wild-type nerves (Fig.
4B). We found that, although IL-6 does not attract macrophages
(above), the medium conditioned by il-6/ cells contained only
40% of the activity present in medium from normal nerves ( p 
0.013), a figure similar to that obtained with medium from lif/
nerves (Fig. 4A). In these experiments, we also examined medium
conditioned by nerves lacking both IL-6 and LIF. Although the
medium from these lif/il-6/ nerves showed a strong reduction
in macrophage recruiting activity when compared with normal
nerves ( p  0.0004), the difference between media from the
double knock-out nerves and media from the corresponding
single knock-out nerves was not statistically significant. This
indicates that both LIF and IL-6 are essential for nerves to
generate maximum chemotactic activity.
The low chemotactic activity in medium from il-6/ nerves
could be explained if the role of IL-6 was to act as a positive
regulator for the generation of downstream chemotactic factors.
First we tested whether IL-6 regulated the expression of mRNAs
for LIF in immunopurified Schwann cells using RT-PCR (Fig.
Figure 2. Schwann cells upregulate MCP-1 mRNA when deprived of
axonal contact. mRNA levels in freshly isolated nerves (N) are compared
with levels in unpurified cultures of dissociated nerve (CO-C) and purified
Schwann cells (SCH ) after overnight incubation. RT-PCR results are
shown for MCP-1-, iNOS-, MIP-1-, and 18S-specific primers. 18S con-
trol samples were used to demonstrate equal loading in all tracks. These
results show that purified Schwann cells upregulate MCP-1 mRNA but
not MIP-1 or iNOS mRNA when they are deprived of axonal contact in
vitro, whereas mixed cultures (containing Schwann cells and fibroblasts)
also upregulate iNOS and MIP-1.
Figure 3. Schwann cells secrete chemotactic activity that is blocked by
anti-MCP-1 and/or anti-LIF antibodies. A, Conditioned medium (CM )
from primary rat Schwann cells (SCH ) contains chemotactic activity that
can be blocked by anti-MCP-1 (-MCP-1) and/or anti-LIF (-LIF )-
neutralizing antibodies. The MCP-1 antibody blocks 60–70% of this activ-
ity ( p  0.0001), whereas the LIF antibody blocks 30–40% of this activity
( p  0.006). When the conditioned medium is incubated with both anti-
bodies, only 15% of the chemotactic activity remains ( p  0.0001). B,
Neutralizing MCP-1 antibodies reduce chemotactic activity in medium
conditioned by RN22 cells by 60% ( p 0.002) in accordance with findings
using conditioned medium from primary Schwann cells. A, B, MCP-1 was
used as a positive control, and MCP-1 in combination with the anti-MCP-1
antibody was used to confirm the effectiveness of the blocking antibody.
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5A). We found that IL-6 strongly increased the abundance of LIF
mRNA from 6 hr onward (significant elevation was seen already
at 1 hr; data not shown) (Fig. 5A). We then tested whether LIF,
being rapidly and therefore presumably directly induced by IL-6,
would, in turn, rapidly induce MCP-1. Using RT-PCR, we deter-
mined that already at 1 and 3 hr, exposure to LIF (20 ng/ml)
clearly increased the levels of MCP-1 mRNA (Fig. 5B). There-
fore, these results suggest the existence of a signaling cascade in
which IL-6 induces LIF, which then induces MCP-1, a model that
is consistent with the sequential activation of these genes in cut
nerves (for references, see above) and our finding that medium
conditioned by il-6/ cells lacks chemotactic activity despite the
fact that IL-6 is not a chemoattractant.
This idea was tested in two additional sets of experiments.
First, it predicts that it might be possible to demonstrate induction
of MCP-1 when IL-6 is added to Schwann cell cultures, although
this effect might be small because it would depend on a sufficient
concentration of LIF building up in the culture dish. Further-
more, because this effect should be indirect and mediated by LIF,
the MCP-1 induction should take place with a delay when com-
pared with the induction of LIF by IL-6. Therefore, we used
RT-PCR to monitor MCP-1 mRNA in purified Schwann cell
cultures after addition of IL-6 (Fig. 5C). Elevation of MCP-1
mRNA was observed, although a significant response was not
seen until at the 10 hr time point. This finding is in agreement
with previous observations that IL-6 does not elevate MCP-1
mRNA in Schwann cells 3 hr after application (Subang and
Richardson, 2001).
Second, if the IL-6-stimulated LIF expression and the LIF-
stimulated MCP-1 expression shown above were functionally
significant, cells exposed to either IL-6 or LIF should generate
more chemotactic activity than unstimulated control cells. To test
this possibility, the RN22 Schwann cell line was treated for 3 hr
with LIF or IL-6 (both at 20 ng/ml). The cells were then washed
extensively to ensure that any added factors were removed from
the wells. Conditioned medium was collected from the cells after
Figure 4. Conditioned medium from nerves of lif/ mice and il-6/
mice shows less chemotactic activity than medium from normal wild-type
nerves (wt). A, Medium conditioned for 24 hr by nerve segments from
lif/ mice contains significantly less chemotactic activity than media
conditioned by nerves from wild-type mice. B, Media conditioned for 24
hr by nerve segments from il-6/ mice or by nerves from mice lacking
both IL-6 and LIF (lif/il-6/) contain significantly less chemotactic
activity than media from wild-type nerves. The difference between media
from il-6/ and lif/il-6/ nerves is not statistically significant. A, B,
MCP-1 (10 ng/ml) was used as a positive control.
Figure 5. IL-6 enhances cytokine expression in Schwann cells. A, IL-6
enhances expression of LIF in purified Schwann cells. The results are
from RT-PCR assays of untreated Schwann cells [controls (C)] and
Schwann cells treated with 20 ng/ml IL-6 for 6 and 24 hr as indicated.
Note that the elevation of LIF mRNA is already clear at 6 hr. 18S control
samples were run as shown to control for loading in all tracks. Densito-
metric comparison of the LIF signals with the corresponding 18S signals
shows that LIF elevation is threefold at 6 hr and sevenfold at 24 hr (see
Materials and Methods). B, LIF enhances expression of MCP-1 in puri-
fied Schwann cells. The results show RT-PCR assays of untreated cells
(C) and Schwann cells treated with 20 ng/ml LIF for 1 and 3 hr as
indicated. Note that the elevation of MCP-1 mRNA is already clear at 1
hr. 18S control samples were run as shown to control for loading in all
tracks. Densitometric comparison of the LIF signals with the correspond-
ing 18S signals shows that MCP-1 elevation is fourfold at 1 hr and fivefold
at 3 hr. C, IL-6 enhances expression of MCP-1 in purified Schwann cells.
The results show RT-PCR assays of untreated cells (C) and cells treated
with 20 ng/ml IL-6 for 6 and 10 hr as indicated. The elevation of MCP-1
mRNA is not unambiguous until the 10 hr point. This delay is consistent
with the idea that IL-6 controls MCP-1 levels indirectly by activating LIF
(Fig. 7). GAPDH PCR was run as shown to control for loading in all
tracks. Densitometric comparison of the LIF signals with the correspond-
ing GAPDH signals shows that MCP-1 elevation is 1.4-fold at 6 hr and
threefold at 10 hr.
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an additional 24 hr incubation in defined medium. We found that
preincubation with either LIF or IL-6 increased macrophage
chemotactic activity by 34% ( p  0.02) and 44% ( p  0.005),
respectively (Fig. 6).
DISCUSSION
Together, the experiments reported here are consistent with the
notions that: (1) Schwann cells directly attract macrophages by
secretion of MCP-1 and LIF and (2) induction of these chemoat-
tractants in denervated Schwann cells is regulated by autocrine
circuits involving IL-6 and LIF (Fig. 7). The existence of such a
signaling cascade and the consequent late elevation of the major
macrophage attractant MCP-1 is in line with the delayed entry
of macrophages into cut nerves in vivo (see the introductory
remarks).
In a functional blocking assay, we show that both MCP-1 and
LIF are present in Schwann cell-conditioned medium, and that
they are the principal mediators of the Schwann cell-derived
chemotactic activity. In our experiments, MCP-1 accounted for
60–70% of Schwann cell chemotactic activity, whereas LIF ac-
counted for 30–40%. In agreement with this, recombinant LIF
has direct chemotactic activity on macrophages in the micro-
chamber assay, with a maximum chemotaxis index that is one-
half that of recombinant MCP-1 (Sugiura et al., 2000). MCP-1
also accounted for 60% of the chemotactic activity secreted by
RN22, a cell line that closely mimics primary Schwann cells in
other aspects of injury and repair responses (Varon et al., 1981;
Longo et al., 1982; Hill, 1987). The role of LIF in chemotaxis is
also supported by two findings. The addition of LIF to primary
Schwann cell cultures induced MCP-1 mRNA, whereas condi-
tioned medium from lif/ mouse sciatic nerves contained sig-
nificantly less chemotactic activity than wild-type controls. Our
data are also consistent with in vivo evidence that macrophage
recruitment to peripheral nerves is reduced in mice lacking the
main receptor for MCP-1 or in lif/ mice after sciatic nerve
and/or brain injury (Siebert et al., 2000; Sugiura et al., 2000).
Because both LIF and IL-6 are known to induce cascades of
inflammatory mediators in other cell types (Villiger et al., 1992;
Hartner et al., 1997; Shimon et al., 1997; Marin et al., 2001), we
investigated whether they could regulate Schwann cell chemotac-
tic activity in a similar manner. IL-6 is not directly chemotactic
for macrophages (Sugiura et al., 2000), but nerve injury in il-6/
mice results in reduced macrophage recruitment (Klein et al.,
1997). Our finding that chemotactic activity secreted by cut
nerves from il-6/ mice is also reduced compared with controls
suggests that this is the reason for the reduced influx of macro-
phages. Treatment of primary Schwann cells with IL-6 induces
LIF at both early (1 and 3 hr) (our unpublished observations) and
more prolonged time points. Furthermore, treatment of RN22
cells with either LIF or IL-6 enhances the chemotactic activity
secreted in the conditioned medium. When combined with evi-
dence from others that IL-6 does not directly induce MCP-1 in
Schwann cells within 3 hr (Subang and Richardson, 2001), our
data suggest that induction of MCP-1 in Schwann cells may be
dependent on previous induction of LIF or other factors that can
induce MCP-1 directly.
Therefore, Schwann cell-derived IL-6 and LIF could induce
the expression of downstream chemotactic signals in Schwann
cells themselves. After nerve transection in vivo, IL-6 mRNA is
Figure 7. A tentative model of a cytokine-signaling cas-
cade controlling macrophage (M) entry to damaged nerves.
An autocrine cascade of IL-6 and LIF enhances Schwann
cell (S) secretion of LIF and MCP-1, both of which directly
attract macrophages. This indirect regulation of the major
macrophage attractant MCP-1 is in agreement with observed
delay in macrophage recruitment to transected nerves in vivo.
Figure 6. Exogenous LIF or IL-6 induces chemotactic activity in the
RN22 Schwann cell line. RN22 cells were treated for 3 hr with 20 ng/ml
LIF or IL-6 and then washed extensively. Conditioned medium (Cond
Medium) was collected from the cells after an additional 24 hr incubation
and tested in the migration assay. LIF and IL-6 increased the level of
chemotactic activity in conditioned medium by 34% ( p  0.02) and 44%
( p  0.005), respectively.
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strongly but transiently induced, reaching peak levels at 12 hr
(Bolin et al., 1995; Bourde et al., 1996; Kurek et al., 1996); LIF
mRNA expression peaks at 24 hr and declines at 3 d postopera-
tively (Banner and Patterson, 1994; Curtis et al., 1994; Kurek et
al., 1996), whereas MCP-1 mRNA reaches peak levels at 48 hr
after axotomy (Chien et al., 1997; Toews et al., 1998). These
observations, together with our present findings, allow us to
propose that in vivo, early induced cytokines such as IL-6 and
weaker chemoattractants such as LIF may be essential Schwann
cell-derived autocrine factors for the expression of stronger
downstream chemotactic signals such as MCP-1 (Fig. 7). In sup-
port of this, axonal breakdown appears to be an important reg-
ulator of IL-6 but not MCP-1 production by Schwann cells
(Rutkowski et al., 1999). It is also of interest that although there
is a very significant deficit in chemotactic activity in the condi-
tioned medium from both lif/ and il-6/ nerves, the activity
did not drop significantly further in conditioned medium from
double knock-out nerves. A related observation was that in re-
sponse to cortical injury, the astroglial and microglial responses to
injury are significantly reduced in the lif/ and il-6/ mice,
but the double knock-out mice show no further reduction in these
responses (Sugiura et al., 2000). Therefore, in both the CNS and
the PNS, these two cytokines seem to operate in series rather than
in parallel, forming one injury response pathway. Supporting the
notion of a single pathway is a recent finding that LIF regulates
IL-6 expression in the complete Freud’s adjuvant model of neuro-
genic cutaneous inflammation (Zhu et al., 2001). The reverse
appears to be true in the sciatic nerve, because IL-6 induces LIF
mRNA in Schwann cells and after nerve cut IL-6 is induced before
LIF (Kurek et al., 1996; Toews et al., 1998). The model proposed
here is also consistent with the observation that after peripheral
nerve damage, the major influx of macrophages begins 2–3 d after
injury (Ramon y Cajal, 1928; Beuche and Friede, 1984; Crang and
Blakemore, 1986; Perry et al., 1987; Clemence et al., 1989; Stoll et
al., 1989). The high potency of MCP-1 and the good correlation of
its time course of induction with peak macrophage recruitment
suggest that the proposed cascade model may represent an impor-
tant window into the inflammatory response.
Although MCP-1 and LIF account very well for the chemotac-
tic activity in Schwann cell-conditioned medium in vivo, other
chemotactic factors or mechanisms are likely to contribute. For
example, cultured Schwann cells produce IL-1 (Bergsteinsdottir
et al., 1991). This cytokine induces both LIF and MCP-1 mRNA
synthesis under some conditions, although it does not induce
MCP-1 in cultured Schwann cells (Carlson et al., 1996; Schwarz
et al., 1997; Subang and Richardson, 2001). TNF-, which is
expressed by Schwann cells 7 d after injury (Wagner and Myers,
1996), induces MCP-1 mRNA when added to Schwann cells, and
although TNF- receptor-null mice do not show lower MCP-1
mRNA levels than wild-type mice in the distal stump at early time
points, they do at 4 d after transection (Subang and Richardson,
2001). In some systems, IL-6 acts in concert with its soluble
receptor to promote leukocyte recruitment and could function
similarly in nerves (Hurst et al., 2001; Marin et al., 2001).
The present observations point to Schwann cells as an impor-
tant target for therapeutic intervention in peripheral nerve dis-
ease. For example, in experimental allergic neuritis, an animal
model for human demyelinating polyneuritis (Guillain Barre
syndrome), upregulation of MCP-1 mRNA precedes the clinical
onset of disease (Fujioka et al., 1999). It remains unclear what
first triggers the upregulation of MCP-1 before overt mononu-
clear cell infiltration. If this situation parallels that of nerve injury
described here, activation of autocrine IL-6/LIF circuits in
Schwann cells by myelin breakdown, in turn promoted by early
recruitment of neuritogenic T cells, could be the mechanism that
stimulates MCP-1 production.
Previous studies have led to the suggestion that a disturbance in
the axon–myelin–Schwann cell unit is sufficient to induce mac-
rophage recruitment, and it is widely accepted that this is the
initiating signal for the inflammatory reaction in peripheral nerve
injury. Axonal breakdown is undoubtedly a key event in Walle-
rian degeneration, and neuron-derived diffusible molecules may
regulate Schwann cell gene expression (Bruck et al., 1995, 1997).
Our findings raise the possibility that Schwann cells are also
active regulators of the early inflammatory response, rather than
simply passive targets of extrinsic signals. This active regulation
could be achieved in part by autocrine circuits, which enhance the
selectivity and potency of the chemotactic activity appropriately
throughout the injury response. It has been shown previously that
Schwann cells can establish autocrine circuits mediated by
insulin-like growth factor, NT-3, and platelet-derived growth
factor-BB, which are sufficient to prevent Schwann cell death in
the absence of axons (Jessen and Mirsky, 1999; Meier et al.,
1999), and that LIF, in combination with other factors, is an
autocrine survival factor for Schwann cells (Dowsing et al., 1999).
Furthermore, axonal contact suppresses LIF mRNA expression
in Schwann cells (Matsuoka et al., 1997). The latter could repre-
sent a physiological mechanism by which regenerating axons
restrict the action of such autocrine circuits during repair. To-
gether with our present data, these findings suggest that expres-
sion of autocrine loops might be a major mechanism by which
Schwann cells regulate gene expression and possibly phenotypic
changes when they are deprived of axonal contact.
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